Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

Summary

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump. The bill directs the Government Accountability Office to report to Congress on access to and the potential diversion of controlled substances administered by injection, implantation, or through the use of an intrathecal pump.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 7 March 2018

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 7 March 2018

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 7 March 2018

  Open at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.